X hits on this document

73 views

0 shares

0 downloads

0 comments

14 / 35

If that weren’t enough, Congress is getting into the action

  • A recently revived proposal in the Senate would give FDA new funding and authority to inspect plants that make prescription drugs and medical devices

  • Legislation introduced in late April by Senators Charles Grassley and Edward Kennedy would authorize FDA:

  • To collect inspection fees from companies

  • To issue subpoenas or detain products when inspectors believe a

product is adulterated or misbranded

© 2009 Hogan & Hartson LLP. All rights reserved.

14

Document info
Document views73
Page views72
Page last viewedSun Dec 04 10:49:20 UTC 2016
Pages35
Paragraphs407
Words3160

Comments